According to Alnylam Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are A$0.10 B. In 2023 the company made an earning of -A$0.47 B an increase over its 2022 earnings that were of -A$1.46 B.The earnings displayed on this page is the company's Pretax Income.